Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Editorial Board Member: Gillery, Philippe / Kazmierczak, Steven / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Whitfield, John B.

12 Issues per year


IMPACT FACTOR 2013: 2.955
Rank 5 out of 29 in category Medical Laboratory Technology in the 2013 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis

Wei-ping Chen1 / Jia-peng Bao1 / Jie Feng1 / Peng-fei Hu1 / Zhong-li Shi1 / Li-dong Wu1

1Department of Orthopedics Surgery, The Second Hospital of Medical College, Zhejiang University, Hangzhou, P.R. China

Corresponding author: Professor Li-dong Wu, PhD, MD, Department of Orthopedics Surgery, The Second Hospital of Medical College, Zhejiang University, JieFang Road 88#, 310009 Hangzhou, P.R. China Phone: +86-571-8778-3578, Fax: +86-571-8702-2776,

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 48, Issue 8, Pages 1141–1145, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2010.230, May 2010

Publication History

Received:
2009-11-02
Accepted:
2010-02-14
Published Online:
2010-05-20

Abstract

Background: The goal of this study was to investigate the distribution of visfatin in paired serum and synovial fluid (SF) samples from patients with osteoarthritis (OA), and in serum from healthy controls. In addition, we wished to determine the potential sources of visfatin in joint tissue.

Methods: Twenty-three patients with OA requiring total knee arthroplasty (TKA), 17 healthy subjects and ten donors requiring amputation were included in the study. Concentrations of visfatin in serum and SF were analyzed using an enzyme-linked immunosorbent assay (ELISA). The concentration of visfatin was also measured in conditioned media from cultured joint tissues.

Results: We found serum visfatin concentrations to be higher in patients with OA compared to healthy controls (p<0.05), and SF-visfatin concentrations exceeded those in paired serum (p=0.004). In addition, infrapatellar fat pad and synovium were important sources of visfatin, while osteophytes released largest amounts of visfatin. Therefore, osteophytes can be considered a major source of visfatin in the knee joint in patients with OA.

Conclusions: These results suggest that visfatin may be involved in the pathophysiology of OA and may have local effects in the joint during the process of OA.

Clin Chem Lab Med 2010;48:1141–5.

Keywords: joint tissues; osteoarthritis; serum; synovial fluid; visfatin

Comments (0)

Please log in or register to comment.
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.